Department of interventional neuroradiology, Lariboisière Hospital, Paris, France.
EA 7334 REMES, Université Paris 7, Paris, France.
J Neurointerv Surg. 2018 Aug;10(8):761-764. doi: 10.1136/neurintsurg-2018-013763. Epub 2018 Mar 6.
To identify the prevalence and therapeutic consequences of spontaneous intracranial artery dissection (IAD) at the acute phase of ischemic stroke.
We reviewed clinical and imaging data of consecutive patients attending our center for mechanical thrombectomy (MT) between January 2012 and November 2017. IAD was defined according to published criteria and our own angiographic criteria (no clot following MT, and normalization of the vessel caliber after stenting).
IAD was retrospectively diagnosed in 13/391 (3%) patients (inter-rater agreement κ=0.885, P<0.001). It was an extending of extracranial dissection in 7/13 (54%) patients. A total of 21 recanalization approaches (with or without IV tissue plasminogen activator) were analyzed in 13 patients. A medical approach was used in 7/21 (33%), MT in 7/21 (33%) (stent retriever=6, thromboaspiration=1), and permanent stenting in 7/21 (33%). A rescue recanalization was necessary after 8/14 (57%) approaches without stenting. Stenting was associated with a best rate of recanalization (P=0.001) and with a trend towards a lower rate of ischemic recurrence (P=0.057). Stenting of a circulating false lumen failed to recanalize the artery in two patients. At the last follow-up, no patient had developed a subarachnoid hemorrhage due to the dissection. The outcome at 3 months was favorable in 8/13 (62%) patients. One patient died at 3 weeks owing to a severe cerebellar infarction.
IAD is a rare diagnosis that should be systematically considered in patients with intracranial large vessel occlusion, especially in patients with extracranial artery dissection and when MT does not retrieve any clot. Stenting of IAD as first-line approach should be assessed in further studies.
明确缺血性卒中急性期自发性颅内动脉夹层(IAD)的发生率和治疗结果。
我们回顾了 2012 年 1 月至 2017 年 11 月期间在我们中心接受机械血栓切除术(MT)的连续患者的临床和影像学资料。根据已发表的标准和我们自己的血管造影标准(MT 后无血栓,支架置入后血管口径正常)定义 IAD。
回顾性诊断 13/391(3%)例患者存在 IAD(组内一致性 κ=0.885,P<0.001)。其中 7/13(54%)例为颅外夹层延伸。对 13 例患者的 21 种再通方法(有或无静脉内组织型纤溶酶原激活剂)进行了分析。7/21(33%)例采用药物治疗,7/21(33%)例采用 MT(支架取栓器=6,血栓抽吸=1),7/21(33%)例采用永久性支架置入。8/14(57%)无支架置入的方法需要进行挽救性再通。支架置入与再通率更高相关(P=0.001),且与缺血性复发率较低呈趋势相关(P=0.057)。2 例患者的循环假腔支架置入未能再通动脉。最后一次随访时,没有患者因夹层而发生蛛网膜下腔出血。13 例患者中有 8/13(62%)预后良好。1 例患者在 3 周时因严重小脑梗死死亡。
IAD 是一种罕见的诊断,在颅内大血管闭塞患者中应系统考虑,尤其是在存在颅外动脉夹层和 MT 未能取出任何血栓的患者中。进一步研究应评估 IAD 的支架置入作为一线治疗方法。